Michael Farris Waters

• Icahn School of Medicine at Mount Sinai

Sources: reporter.nih.gov

• National Institute of Neurological Disorders and Stroke

  R56, Improving VCID outcomes incident to ischemic stroke through mitigation of neutrophil extracellular traps, R56NS139353, 2026–2027, 28 Aug 2026

• National Institute of Neurological Disorders and Stroke

  U44, Dodecafluoropentane emulsion (DDFPe), NanO2™ as Cerebroprotectant in Ischemic Stroke, U44NS130589, 2023–2026, 7 May 2025

Sources: reporter.nih.gov